Literature DB >> 17515502

Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.

Alexander Golger1, Diana S Young, Danny Ghazarian, Peter C Neligan.   

Abstract

OBJECTIVES: To describe the epidemiological features of cutaneous head and neck melanoma (CHNM) and to identify factors associated with mortality from this disease.
DESIGN: A population-based cohort study.
SETTING: Patients treated for CHNM in Ontario between January 1, 1994, and December 31, 2002, were identified through the provincial Cancer Registry. A Cox proportional hazards regression model was used to analyze the data. PATIENTS: A total of 2218 patients with CHNM were identified, comprising 15.8% of all melanomas in Ontario. The mean age of the cohort was 66 years (SD, 16 years); 1363 patients (61.5%) were males. MAIN OUTCOME MEASURE: Patients' vital status (dead or alive).
RESULTS: The incidence of CHNM increased from 2.0 per 100,000 in 1996 to 2.7 per 100,000 in 2001, while mortality remained stable. The Cox proportional hazards regression model showed that increased age (hazard ratio [HR], 1.06; 95% confidence interval [CI], 1.04-1.06) and male sex (HR, 1.31; 95% CI, 1.03-1.66) had a significantly higher risk of death. Patients with lesions of the scalp and neck had a 53% higher risk of death than those with lesions of the face. Nodular melanoma (HR, 1.61; 95% CI, 1.17-2.24) had the worst prognosis compared with other morphological types. Increased tumor thickness (HR, 1.05; 95% CI, 1.03-1.07), ulceration (HR, 1.53; 95% CI, 1.08-2.07), and Clark level V (HR, 1.52; 95% CI, 1.01-2.22) were significantly associated with increased mortality.
CONCLUSIONS: Our study demonstrated an increase in the incidence of CHNM. Advanced age, male sex, nodular morphological features, tumor thickness, ulceration, and Clark level V carried a significant risk of death, whereas facial melanomas had a favorable prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17515502     DOI: 10.1001/archotol.133.5.442

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  14 in total

1.  Tumor location predicts survival in cutaneous head and neck melanoma.

Authors:  Warren H Tseng; Steve R Martinez
Journal:  J Surg Res       Date:  2010-11-10       Impact factor: 2.192

2.  Burden of illness for metastatic melanoma in Canada, 2011-2013.

Authors:  D S Ernst; T Petrella; A M Joshua; A Hamou; M Thabane; S Vantyghem; F Gwadry-Sridhar
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database.

Authors:  Steven M Sperry; Mary E Charlton; Nitin A Pagedar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

4.  Primary Alopecia Neoplastica: A Novel Case Report and Literature Review.

Authors:  Kelly E Flanagan; Laura J Burns; James T Pathoulas; Chloe J Walker; Isabel Pupo Wiss; Kristine M Cornejo; Maryanne M Senna
Journal:  Skin Appendage Disord       Date:  2021-06-16

5.  Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

Authors:  Bruce Ng; Jan Zakrzewski; Melanie Warycha; Paul J Christos; Dean F Bajorin; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Anthony Montgomery; Leonard Liebes; Peter C Brooks; Iman Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 6.  The Prognostic Value of Age, Sex, and Subsite in Cutaneous Head and Neck Melanoma: A Clinical Review of Recent Literature.

Authors:  Sameep Kadakia; David Chan; Moustafa Mourad; Yadranko Ducic
Journal:  Iran J Cancer Prev       Date:  2016-06-08

7.  Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.

Authors:  Robert H I Andtbacka; Sanjiv S Agarwala; David W Ollila; Sigrun Hallmeyer; Mohammed Milhem; Thomas Amatruda; John J Nemunaitis; Kevin J Harrington; Lisa Chen; Mark Shilkrut; Merrick Ross; Howard L Kaufman
Journal:  Head Neck       Date:  2016-07-13       Impact factor: 3.147

8.  Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and Neck.

Authors:  Renee P Wood; Jane S Heyworth; Nina S McCarthy; Audrey Mauguen; Marianne Berwick; Nancy E Thomas; Michael J Millward; Hoda Anton-Culver; Anne E Cust; Terence Dwyer; Richard P Gallagher; Stephen B Gruber; Peter A Kanetsky; Irene Orlow; Stefano Rosso; Eric K Moses; Colin B Begg; Sarah V Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

9.  Incidence of Cutaneous Melanoma of Eyelid Analysis of the Surveillance, Epidemiology, and End Results Database.

Authors:  Philip Brunetti; Curtis E Margo; Dustin D French
Journal:  Ocul Oncol Pathol       Date:  2020-11-17

10.  Different aspects of self-reported quality of life in 450 german melanoma survivors.

Authors:  Annika Waldmann; Sandra Nolte; Ron Pritzkuleit; Eckhard W Breitbart; Alexander Katalinic
Journal:  Cancers (Basel)       Date:  2011-05-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.